Hepatic copper concentration is high in patients with Wilson's disease (Cumings, 1948) and is responsible for the liver damage (Sternlieb, 1972) . Patients with the untreated disease usually have liver copper concentrations above 4 0 mmol/kg of dry liver, normal range 0-25-0 90 mmol/kg (Sternlieb and Scheinberg, 1968) . Approximately 80 % of absorbed copper is normally excreted in bile and lost in the faces (Cartwright and Wintrobe, 1964) , and the cholestasis of primary biliary cirrhosis (PBC) and long-standing extrahepatic biliary obstruction can cause elevation of liver copper concentrations above 40 mmol/kg (Hunt et al., 1963; Smallwood et al., 1968) . Some patients with chronic active hepatitis (CAH) and alcoholic cirrhosis also have raised liver copper concentrations, but not to the levels found in Wilson's disease and PBC (Smallwood et al., 1968; Fleming et al., 1974) .
Cytoplasmic material, which stains with orcein, has been found in the same cellular and subcellular locations as stainable copper in liver biopsy specimens from patients with prolonged cholestasis.
Received for publication 12 January 1978 This suggests that copper is retained in copperprotein complexes in the cytoplasm (Salaspuro and Sipponen, 1976; Sipponen, 1976) as a result of cholestasis of any cause.
In order to evaluate different methods of demonstrating excess copper in patients with chronic liver disease, we have compared the results of liver copper measurement by neutron activation analysis with copper staining by rubeanic acid and rhodanine, and with staining of copper-associated protein by the orcein method.
Material and methods NEUTRON ACTIVATION ANALYSIS (NAA) Percutaneous liver biopsies were performed with Menghini needles, which were prepared by washing in a 1 % solution of ethylene-diamine-tetra-acetic acid (EDTA) to remove surface copper. A sample of each biopsy was separated, freeze-dried, weighed, and submitted for NAA by the technique of Todd et al. (1967) .
Histological demonstration of copper and copper-associated protein in chronic liver diseases microns, were fixed in neutral buffered formolsaline. The sections were stained with rubeanic acid (Cook, 1974) , with reagent supplied by Raymond A. Lamb, London, using the staining solution at room temperature for 24 hours, and with rhodanine (BDH Chemicals Ltd) by the method of Lindquist (1969) . The sections were also stained by Shikata's orcein method (BDH Chemicals Ltd), using a modified oxidising solution (Deodhar et al., 1975) . This stains sulphonic acid residues formed from sulphydryl groups during oxidation, including hepatitis B surface antigen (HB5Ag) (Shikata et al., 1974) , a copper-associated protein (Salaspuro and Sipponen, 1976) , and elastic fibres.
Each slide was examined by one observer (PJS) without knowledge of the liver copper concentration of the biopsy specimen, and the degree of staining by each of the three methods was scored 0 to 3. where O was negative, 1 minimal, 2 positive, and 3 heavy staining (Fig. 1 (Howell, 1959) and which can be dissolved in alcohol, was used to remove copper from sections (Scheuer and Barka, 1963) . Because removal of the coloured compound can be checked optically, this method was preferred to non-specific copper-removing procedures such as the permanganate-oxalic acid step in the orcein method (Deodhar et al., 1975 ). Mallory's haematoxylin method for copper (Mallory and Parker, 1939) S. Jain, P. J. Scheuer, Barbara Archer, S. P. Newman, and Sheila Sherlock haematoxylin, and is thus considered very specific for the method. As shown in Table 1 , staining by Mallory's haematoxylin, rhodanine, and rubeanic acid was prevented by prior removal of copper by means of DTC and alcohol. Shikata's orcein staining was not affected. This is in agreement with the conclusion of Salaspuro and Sipponen (1976) , that orcein stains a copper-binding protein rather than copper itself. Problems of technique and interpretation of the different staining methods were relatively minor. There was gradual fading of rhodanine staining over a period of several days, particularly in biopsy specimens from patients with PBC and when copper was scanty. A similar problem was noted by Lindquist (1969) , using Permount as a mounting medium for the sections. In our experiments, the degree of fading differed according to the mounting medium used. This was greatest with Eukitt, less with DPX and Diatex, and least with Ralmount (all products of Raymond A. Lamb). 
Results
The six histologically normal liver biopsy specimens had copper concentrations of below 0-9 mmol/kg and did not stain with rubeanic acid, rhodanine, or orcein.
PBC
Liver copper concentration measured by NAA was elevated in 31 of the 35 specimens; the range was 052-22-03 mmol/kg dry liver. Thirty of the 35 specimens showed positive staining for copper by rubeanic acid. One of these had a normal liver copper concentration, and two with elevated copper had negative staining, therefore discrimination between normal and elevated liver copper concentration by rubeanic acid staining was correct in 32 of the 35 biopsy specimens (Fig. 3) . The grade of copper stain-2?. 
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14. (Sternlieb and Scheinberg, 1968) . Copper accumulation may perpetuate liver damage in PBC, so liver copper concentrations have been measured in trials of D-penicillamine treatment, which have found that the drug improves serum liver function tests (Jain et al., 1977) and may improve survival (Dickson et al., 1977) .
Direct staining of liver sections in PBC was useful in discriminating between normal and elevated liver copper but did not give a reliable indication of the liver copper concentration. However, strongly positive (grade 3) staining was associated only with copper levels above 3-23 mmol/kg and may therefore influence the decision to use chelation therapy. The rubeanic acid stain gave better correlation with the liver copper concentration, but the dull colour of rubeanic acid was not so easily discernible as the orange-red of rhodanine, making the latter more suitable for routine use. Irons et al. (1977) (Evans, 1971) . Production of an abnormal metal-binding protein in Wilson's disease has been suggested but not confirmed (Evans et al., 1973) .
Our findings of positive staining for copper by rubeanic acid in only six of 17 patients with Wilson's disease, though similar to those of Dastur and Manghani (1967) , were in contrast to those of Goldfischer and , who found positive staining by a similar technique in 14 of their 16 cases. However, the mean liver concentration in their patients was 1-6 times higher than those reported here.
In both types of CAH, orcein staining corresponded well with copper staining, but none of the stains gave a reliable guide to the liver copper concentration, which was frequently elevated when staining was negative. This suggests that, as in Wilson's disease, rubeanic acid and rhodanine can stain only copper, that is associated with proteins with sulphydryl groups, but that excess copper can also be present in another form. Sipponen et al. (1975) found positive orcein staining in 20% of CAH patients, and 83 % in PBC. They suggested that the presence of a copperbinding protein might be used for differential diagnosis. We have found positive orcein staining in five of eight patients (62.5 %) with HB&Ag negative CAH, and in 33 of 35 (94.3 %) with PBC, and do not therefore consider that the stain can distinguish reliably between the two diseases. However, grade 3 copper staining was not seen in any of the biopsy specimens from patients with CAH.
In CAH the liver copper concentration is usually below 4.0 mmol/kg, and copper accumulation probably does not present a clinical problem.
